Ultac 150 mg (Tablet)
Unit Price: ৳ 1.50 (10 x 10: ৳ 150.00)
Strip Price: ৳ 15.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Aexim pharmaceuticals ltd |
Title
- Ultac Ranitidine Tablet & Syrup
Categories
- Medicine
- Gastric Acid Reducer
- Ulcer Treatment
- Reflux Disease Aid
Description
- Ultac is indicated for the treatment of active duodenal ulcer, benign gastric ulcer, Zollinger-Ellison Syndrome, gastroesophageal reflux disease (GERD), post-operative stress ulcer, and more. It competitively blocks histamine at H2-receptors of the gastric parietal cells, inhibiting gastric acid secretion. It is available in tablet and syrup form for oral administration, as well as in IV injection and IV infusion for parenteral administration. It may interact with certain medications and has contraindications for hypersensitive patients. The medicine is generally well tolerated with uncommon side effects, can be used with precautions in certain populations, and has specific storage conditions.
Dimensions
- Tablet: various sizes
- Syrup: various bottle sizes
- IV Injection/Infusion: specific volumes for dilution
Color Options
- N/A
Functions
- Treatment of active duodenal ulcer
- Benign gastric ulcer treatment
- Prevention of ulcer associated with non-steroidal anti-inflammatory agent
- Reflux oesophagitis treatment
- Zollinger Ellison syndrome treatment
- Maintenance for preventing recurrences
Materials
- Active ingredient: Ranitidine
- Tablet formulation: excipients as per formulation
- Syrup formulation: excipients as per formulation
Technical Specifications
- Dosage: varied dosages based on indication and patient population
- Interaction: delayed absorption and increased peak serum concentration with propantheline bromide, minimal inhibition of hepatic metabolism of certain drugs, potential alteration of absorption of pH-dependent drugs, reduced bioavailability with antacids
Design Elements
- Distinct packaging design for tablets and syrup
- Specific labeling for dosage instructions and precautions
Usability Features
- Oral administration for tablets and syrup
- Parenteral administration for IV injection and IV infusion
Pregnancy & Lactation
- Ranitidine crosses the placenta, caution during pregnancy
- Excreted in human breast milk, caution during lactation
Precautions & Warnings
- Reduced dosage for patients with impaired renal and hepatic function
Special Populations
- Elderly patients: similar ulcer healing rates and adverse effects incidence compared to younger patients
Overdose Effects
- No particular problems expected following overdosage
- Symptomatic and supportive therapy recommended
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Specific instructions for dilution and preparation for slow IV injection, intermittent slow IV infusion, continuous IV infusion, and patients with hypersecretory conditions
Storage Conditions
- Store in a cool and dry place
- Protect from light